Equity Asset Valuation (CFA Institute Investment Series) – 2nd edition
Original price was: $85.67.$4.99Current price is: $4.99. & Free Shipping
With the Second Edition of Equity Asset Valuation, the distinguished team of Jerald Pinto, Elaine Henry, Thomas Robinson, and John Stowe, fully update information associated with this important discipline. Blending theory with practice, they detail the contemporary techniques used to determine the intrinsic value of an equity security, and show you how to successfully apply these techniques in both foreign and domestic markets. 467 Pages · 2010 · 2.91 MB · English
Start reading immediately after purchase!
- Satisfaction Guaranteed
- No Hassle Refunds
- Secure Payments
Description
A comprehensive look at the equity valuation process
With the Second Edition of Equity Asset Valuation, the distinguished team of Jerald Pinto, Elaine Henry, Thomas Robinson, and John Stowe, fully update information associated with this important discipline. Blending theory with practice, they detail the contemporary techniques used to determine the intrinsic value of an equity security, and show you how to successfully apply these techniques in both foreign and domestic markets.
Unlike alternative works in this field, the Second Edition of Equity Asset Valuation clearly integrates finance and accounting concepts into the discussion-providing the evenness of subject matter treatment, consistency of notation, and continuity of topic coverage that is so critical to the learning process.
- Addresses essential issues in this arena, including the equity valuation process, discounted dividend valuation, free cash flow valuation, and residual income valuation
- Each author brings his own unique experiences and perspectives to the equity analysis process
- Distills the knowledge, skills, and abilities you need to succeed in today’s fast-paced financial environment
- Companion Workbook also availableValuable for classroom study, self-study, and general reference, this book contains clear, example-driven coverage of many of today’s most important valuation issues.
Reviews
There are no reviews yet.